Nyxoah (NASDAQ:NYXH) Issues Quarterly Earnings Results, Misses Expectations By $0.03 EPS

Nyxoah (NASDAQ:NYXH) posted its quarterly earnings results on Thursday. The company reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.46) by ($0.03), Zacks reports. Nyxoah had a negative net margin of 1,043.93% and a negative return on equity of 51.68%.

Nyxoah Price Performance

Shares of NASDAQ NYXH opened at $10.51 on Friday. Nyxoah has a twelve month low of $6.76 and a twelve month high of $20.00. The company has a current ratio of 5.28, a quick ratio of 4.95 and a debt-to-equity ratio of 0.21. The company has a market capitalization of $357.97 million, a price-to-earnings ratio of -5.62 and a beta of 1.42. The firm has a 50-day moving average of $10.29 and a two-hundred day moving average of $9.18.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on NYXH shares. HC Wainwright restated a “buy” rating and set a $17.00 price target on shares of Nyxoah in a research report on Friday, December 13th. Stifel Nicolaus lowered their price target on shares of Nyxoah from $16.00 to $15.00 and set a “buy” rating for the company in a research report on Friday.

About Nyxoah

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.